Publication Author: Basu_Anirban
-
The cost of observation care for commercially insured patients visiting the emergency department.
Sabbatini AK, Wright B, Hall MK, Basu A. The cost of observation care for commercially insured patients visiting the emergency department. Am J Emerg Med. 2018 Jan 21. pii: S0735-6757(18)30040-8. doi: 10.1016/j.ajem.2018.01.040. [Epub ahead of print]
rakerr2
-
The effect of prenatal exposure to Ramadan on children’s height.
Karimi SM, Basu A. The effect of prenatal exposure to Ramadan on children’s height. Econ Hum Biol. 2018 Jun 25;30:69-83. doi: 10.1016/j.ehb.2018.05.001. [Epub ahead of print]
rakerr2
-
The Value of Outpatient Imaging-Based Cancer Screening Episodes.
Liao JM, Basu A, Lee CI. The Value of Outpatient Imaging-Based Cancer Screening Episodes. J Gen Intern Med. 2018 Jul 18. doi: 10.1007/s11606-018-4571-y. [Epub ahead of print]
rakerr2
-
Integrating value of research into NCI Clinical Trials Cooperative Group research review and prioritization: A pilot study.
Carlson JJ, Kim DD, Guzauskas GF, Bennette CS, Veenstra DL, Basu A, Hendrix N, Hershman DL, Baker L, Ramsey SD. Integrating value of research into NCI Clinical Trials Cooperative Group research review and prioritization: A pilot study. Cancer Med. 2018 Ju
rakerr2
-
Does Maternity Care Coordination Influence Perinatal Health Care Utilization? Evidence from North Carolina.
Hillemeier MM, Domino ME, Wells R, Goyal RK, Kum HC, Cilenti D, Basu A. Does Maternity Care Coordination Influence Perinatal Health Care Utilization? Evidence from North Carolina. Health Serv Res. 2017 Jul 20. doi: 10.1111/1475-6773.12742. [Epub ahead of
rakerr2
-
Projecting the Potential Effect of Using Paliperidone Palmitate Once-Monthly and Once-Every-3-Months Long-Acting Injections Among Medicaid Beneficiaries with Schizophrenia.
Basu A, Benson C, Alphs L. Projecting the Potential Effect of Using Paliperidone Palmitate Once-Monthly and Once-Every-3-Months Long-Acting Injections Among Medicaid Beneficiaries with Schizophrenia. J Manag Care Spec Pharm. 2018 Aug;24(8):759-768. doi: 1
rakerr2
-
Economic Value of Greater Access to Bariatric Procedures for Patients With Severe Obesity and Diabetes.
Kim DD, Arterburn DE, Sullivan SD, Basu A. Economic Value of Greater Access to Bariatric Procedures for Patients With Severe Obesity and Diabetes. Med Care. 2018 Jul;56(7):583-588. doi: 10.1097/MLR.0000000000000924.
rakerr2
-
2SLS versus 2SRI: Appropriate methods for rare outcomes and/or rare exposures.
Basu A, Coe NB, Chapman CG. 2SLS versus 2SRI: Appropriate methods for rare outcomes and/or rare exposures. Health Econ. 2018 Jun;27(6):937-955. doi: 10.1002/hec.3647. Epub 2018 Mar 26.
rakerr2
-
Alternative evaluation metrics for risk adjustment methods.
Park S, Basu A. Alternative evaluation metrics for risk adjustment methods. Health Econ. 2018 Jun;27(6):984-1010. doi: 10.1002/hec.3657. Epub 2018 Mar 26.
rakerr2
-
Decision Criterion and Value of Information Analysis: Optimal Aspirin Dosage for Secondary Prevention of Cardiovascular Events.
Basu A, Meltzer D. Decision Criterion and Value of Information Analysis: Optimal Aspirin Dosage for Secondary Prevention of Cardiovascular Events. Med Decis Making. 2018 Mar 1:272989X17746988. doi: 10.1177/0272989X17746988. [Epub ahead of print]
rakerr2